MicuRx Pharmaceuticals, Inc.
Biotechnology ResearchCalifornia, United States11-50 Employees
MicuRx Pharmaceuticals is a biotechnology company based out of Foster City, California USA and Shanghai, China.
Strong Funding Position With a substantial funding amount of 107 million USD and recent investments from Legend Capital, MicuRx Pharmaceuticals demonstrates strong financial backing, providing a solid foundation for expansion and new product development opportunities.
Innovative R&D Recognition The company has been recognized for its research excellence, including awards for Contezolid tablets, indicating a proven track record in developing innovative therapies that can be targeted for commercialization and licensing deals.
Expanding Clinical Research MicuRx is actively presenting multiple clinical and preclinical studies at major conferences like ESCMID Global 2025, highlighting ongoing advancements in antimicrobial treatments that could meet unmet medical needs in infectious disease markets.
Market Expansion Potential With its operations in both the United States and China, MicuRx is positioned to leverage cross-border market opportunities, particularly in antimicrobial therapeutics, appealing to global healthcare providers and payers.
Focus on Innovative Treatments The company's development of MRX-5 for refractory NTM infections and recognition for health product innovation suggest a strategic focus on addressing high-need, challenging infections, creating potential upsell or partnership opportunities in niche markets.
MicuRx Pharmaceuticals, Inc. uses 8 technology products and services including WordPress, Google Fonts API, GSAP, and more. Explore MicuRx Pharmaceuticals, Inc.'s tech stack below.
| MicuRx Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@micurx.com | 89% |
| First@micurx.com | 7% |
| Last@micurx.com | 4% |
Biotechnology ResearchCalifornia, United States11-50 Employees
MicuRx Pharmaceuticals is a biotechnology company based out of Foster City, California USA and Shanghai, China.
MicuRx Pharmaceuticals, Inc. has raised a total of $107M of funding over 8 rounds. Their latest funding round was raised on Dec 21, 2020 in the amount of $107M.
MicuRx Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M
MicuRx Pharmaceuticals, Inc. has raised a total of $107M of funding over 8 rounds. Their latest funding round was raised on Dec 21, 2020 in the amount of $107M.
MicuRx Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M